How I treat ovarian cancer in older women Journal Article


Author: Lichtman, S. M.
Article Title: How I treat ovarian cancer in older women
Abstract: Advancing age in patients with epithelial ovarian cancer is a risk factor for decreased survival. The exact cause is unknown but part of this may be due to less than adequate therapy for these patients. To optimize treatment, this paper presents the available data for therapy and my own approach in the management of this disease. For optimal outcomes, there also needs to be a close collaboration between subspecialists (gynecologic oncology, medical oncology, pathology) in all aspects of treatment planning. Progression-free and overall survival can be prolonged and patients' quality of life can be maintained with appropriate management. © 2014 Elsevier Inc.
Keywords: cancer chemotherapy; aged; overall survival; review; cancer recurrence; bevacizumab; cisplatin; doxorubicin; cancer combination chemotherapy; patient selection; unspecified side effect; gemcitabine; paclitaxel; topotecan; neurotoxicity; ovarian cancer; cytoreductive surgery; carboplatin; progression free survival; quality of life; multiple cycle treatment; nephrotoxicity; ovary cancer; pain; anemia; bone marrow suppression; blood toxicity; leukopenia; nausea; neuropathy; vomiting; cyclophosphamide; tumor regression; cancer resistance; comorbidity; ca 125 antigen; platinum complex; taxane derivative; alopecia; digestive system perforation; elderly; allergic reaction; geriatric assessment; respiratory tract disease; electrolyte disturbance; venous thromboembolism; ototoxicity; patient preference; intraperitoneal; cancer prognosis; serous ovarian cancer; infusion related reaction; human; female; priority journal
Journal Title: Journal of Geriatric Oncology
Volume: 5
Issue: 3
ISSN: 1879-4068
Publisher: Elsevier Inc.  
Date Published: 2014-07-01
Start Page: 223
End Page: 229
Language: English
DOI: 10.1016/j.jgo.2014.06.001
PROVIDER: scopus
PUBMED: 24954887
DOI/URL:
Notes: Export Date: 2 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stuart Lichtman
    228 Lichtman